GROUP ONE TRADING, L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$334,000
-22.9%
9,656
-43.1%
0.00%
Q3 2021$433,000
-83.3%
16,985
-73.3%
0.00%
-100.0%
Q1 2021$2,590,000
-53.3%
63,552
-50.3%
0.00%
-60.0%
Q4 2020$5,543,000
+274.3%
127,994
+376.5%
0.01%
+100.0%
Q3 2020$1,481,000
+62.0%
26,861
+85.5%
0.01%
+25.0%
Q2 2020$914,000
-53.0%
14,481
-61.9%
0.00%
-75.0%
Q1 2020$1,943,000
+237.3%
38,040
+220.2%
0.02%
+220.0%
Q3 2019$576,000
-73.9%
11,880
-71.7%
0.01%
-75.0%
Q2 2019$2,208,000
+62.2%
41,972
+26.6%
0.02%
+66.7%
Q4 2018$1,361,000
+239.4%
33,153
+214.1%
0.01%
+300.0%
Q3 2018$401,000
-82.1%
10,556
-78.7%
0.00%
-84.2%
Q2 2018$2,235,000
+48.6%
49,457
+29.4%
0.02%
+72.7%
Q4 2017$1,504,000
+966.7%
38,216
+741.8%
0.01%
+1000.0%
Q3 2017$141,000
-10.8%
4,540
-21.4%
0.00%
-50.0%
Q2 2017$158,000
-91.6%
5,776
-88.7%
0.00%
-90.9%
Q1 2017$1,881,000
+37520.0%
51,035
+18257.9%
0.02%
Q2 2016$5,000
-90.6%
278
-91.7%
0.00%
-100.0%
Q1 2016$53,0003,3690.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders